PMP–diketopiperazine adducts form at the active site of a PLP dependent enzyme involved in formycin biosynthesis
Year: 2019
Type: article
Abstract: ForI is a PLP-dependent enzyme from the biosynthetic pathway of the C-nucleoside antibiotic formycin. Cycloserine is thought to inhibit PLP-dependent enzymes by irreversibly forming a PMP-isoxazole. We now report that ForI forms novel PMP-diketopiperazine derivatives following incubation with both d and l cycloserine. This unexpected result suggests chemical diversity in the chemistry of cycloserine inhibition.
Source: Chemical Communications
DOI: 10.1039/c9cc06975e
Institutions: University of St Andrews, Research Complex at Harwell, University of Florida, QB3, University of California System, Institute for Quantitative Biosciences, The University of Tokyo, University of California, Berkeley, Foundation for Applied Molecular Evolution, Cardiff University, Sichuan University, University of Oxford, Rosalind Franklin Institute, State Key Laboratory of Biotherapy
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2987080839
